Xeris Biopharma Holdings Inc (XERS)

Financing Cash Flow

$6.69M

TTM · Period ending: · USD

XERS logo

XERS Financing Cash Flow

Latest reported$6.69M
XERS TTM Cash from Financing ($35.14M → $6.69M)
High-resolution chart · PNG

XERS financing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Xeris Biopharma Holdings Inc Financing Cash Flow — Trailing twelve months (TTM) (USD)
Period endingFinancing Cash Flow (USD)
6,690,000
5,689,000
11,389,000
12,053,000
-1,880,000
-2,163,000
36,168,000
35,721,000
35,732,000
35,629,000
-428,000
48,777,000
48,662,000
48,416,000
127,473,000
78,442,000
78,630,000
78,780,000
27,247,000
30,448,000
43,510,000
112,658,000
126,064,000
124,708,000
134,215,000
64,450,000
80,530,000
78,589,000
69,202,000
160,155,000
128,211,000
133,649,000
120,485,000
59,710,000
35,139,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.